Myasthenia gravis epidemiology and demographics
|
Myasthenia gravis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myasthenia gravis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Myasthenia gravis epidemiology and demographics |
|
Risk calculators and risk factors for Myasthenia gravis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Epidemiology and Demographics
Myasthenia gravis occurs in all ethnic groups and both genders. It most commonly affects women under 40 - and people from 50 to 70 years old of either sex, but it has been known to occur at any age. Younger patients rarely have thymoma. The prevalence in the United States is estimated at 20 cases per 100,000 in the United States.[1] Risk factors are the female gender with ages 20 – 40, familial myasthenia gravis, D-penicillamine ingestion (drug induced myasthenia), and having other autoimmune diseases.
Three types of myasthenia symptoms in children can be distinguished:
- Neonatal: In 12% of the pregnancies with a mother with MG, she passes the antibodies to the infant through the placenta causing neonatal myasthenia gravis. The symptoms will start in the first two days and disappear within a few weeks after birth. With the mother it is not uncommon for the symptoms to even improve during pregnancy, but they might worsen after labor.
- Congenital: Children of a healthy mother can, very rarely, develop myasthenic symptoms beginning at birth. This is called Congenital Myasthenic Syndrome or CMS. Other than Myasthenia gravis, CMS is not caused by an autoimmune process, but due to synaptic malformation, which in turn is caused by genetic mutations. Thus, CMS is a hereditary disease. More than 11 different mutations have been identified and the inheritance pattern is typically autosomal recessive.
- Juvenile myasthenia gravis: myasthenia occurring in childhood but after the peripartum period.
The congenital myasthenias cause muscle weakness and fatigability similar to those of MG. The symptoms of CMS usually begin within the first two years of life, although in a few forms patients can develop their first symptoms as late as the seventh decade of life. A diagnosis of CMS is suggested by the following:
- Onset of symptoms in infancy or childhood.
- Weakness which increases as muscles tire.
- A decremental EMG response, on low frequency, of the compound muscle action potential (CMAP).
- No anti-AChR or MuSK antibodies.
- No response to immunosuppressant therapy.
- Family history of symptoms which resemble CMS.
The symptoms of CMS can vary from mild to severe. It is also common for patients with the same form, even members of the same family, to be affected to differing degrees. In most forms of CMS weakness does not progress, and in some forms, the symptoms may diminish as the patient gets older. Only rarely do symptoms of CMS become worse with time.
References
- ↑ "What is Myasthenia Gravis (MG)?". Myasthenia Gravis Foundation of America.